TerSera Therapeutics

TerSera Therapeutics is a biopharmaceutical company committed to enhancing patient care by building innovative therapies and ensuring their delivery to those in need. The company focuses on developing patient-first solutions backed by scientific expertise and comprehensive support services, aiming for meaningful outcomes in healthcare. TerSera recently acquired MARGENZA® (margetuximab-cmkb), expanding its portfolio of unique therapeutics. Dedicated to addressing unmet medical needs, TerSera leverages its knowledge in advancing one-of-a-kind treatments, striving for significant impacts in human health.